Preparation and characterization of novel albumin-sericin nanoparticles as siRNA delivery vehicle for laryngeal cancer treatment

References

• Fire, A.; Xu, S.; Montgomery, M.K.; Kostas, S.A.; Driver, S.E.; Mello, C.C. Potent and Specific Genetic Interference by Double-Stranded RNA in Caenorhabditis Elegans. Nature. 1998, 391, 806–811.
   PubMed Web of Science ®Google Scholar
• Uprichard, S.L. The Therapeutic Potential of RNA Interference. FEBS Lett. 2005, 579, 5996–6007.
   PubMed Web of Science ®Google Scholar
• Tatiparti, K.; Sau, S.; Kashaw, S.; Iyer, A. siRNA Delivery Strategies: A Comprehensive Review of Recent Developments. Nanomaterials. 2017, 7, 77.
   Web of Science ®Google Scholar
• Kim, V. N. RNA Interference in Functional Genomics and Medicine. J. Korean Med. Sci. 2003, 18, 309–318.
   PubMed Web of Science ®Google Scholar
• Elzoghby, A.O.; Samy, W.M.; Elgindy, N.A. Albumin-Based Nanoparticles as Potential Controlled Release Drug Delivery Systems. J. Control Release. 2012, 157, 168–182.
   PubMed Web of Science ®Google Scholar
• Lohcharoenkal, W.; Wang, L.; Chen, Y.C.; Rojanasakul, Y. Protein Nanoparticles as Drug Delivery Carriers for Cancer Therapy. Biomed. Res. Int. 2014, 2014, 180549.
   PubMed Web of Science ®Google Scholar
• Tarhini, M.; Greige-Gerges, H.; Elaissari, A. Protein-Based Nanoparticles: From Preparation to Encapsulation of Active Molecules. Int. J. Pharm. 2017, 522, 172–197.
   PubMed Web of Science ®Google Scholar
• Cho, K.Y.; Moon, J.Y.; Lee, Y.W.; Lee, K.G.; Yeo, J.H.; Kweon, H.Y.; Kim, K.H.; Cho, C.S. Effect of Methyl Alcohol on the Morphology and Conformational Characteristics of Silk Sericin. Int J Biol. Macromol. 2003, 32, 36–42.
   PubMed Web of Science ®Google Scholar
• Zhang, X.; Khan, M.R.; Yamamoto, T.; Tsukada, M.; Morikawa, H. Fabrication of Silk Sericin Nanofibers from a Silk Sericin-Hope Cocoon with Electrospinning Method. Int. J. Biol. Macromol. 2012, 50, 337–347.
   PubMed Web of Science ®Google Scholar
• Kunz, R.I.; Brancalhão, R.M.C.; Ribeiro, L.F.C.; Natali, M.R.M. Silkworm Sericin: Properties and Biomedical Applications. Biomed. Res. Int. 2016, 2016, 8175701.
   PubMed Web of Science ®Google Scholar
• Ahn, J.S.; Choi, H.K.; Lee, K.H.; Nahm, J.H.; Cho, C.S. Novel Mucoadhesive Polymer Prepared by Template Polymerization of Acrylic Acid in the Presence of Silk Sericin. J. Appl. Polym. Sci. 2001, 80, 274–280.
   Web of Science ®Google Scholar
• Nagura, M.; Ohnishi, R.; Gitoh, Y.; Ohkoshi, Y. Structures and Physical Properties of Cross-Linked Sericin Membranes. J. Insect Biotechnol. Sericol. 2001, 70, 149–153.
   Google Scholar
• Das, S.K.; Dey, T.; Kundu, S.C. Fabrication of Sericin Nanoparticles for Controlled Gene Delivery. RSC Adv. 2014, 4, 2137–2142.
   Web of Science ®Google Scholar
• Guo, W.; Deng, L.; Yu, J.; Chen, Z.; Woo, Y.; Liu, H.; Li, T.; Lin, T.; Chen, H.; Zhao, M.; et al. Sericin Nanomicelles with Enhanced Cellular Uptake and pH-Triggered Release of Doxorubicin Reverse Cancer Drug Resistance. Drug Deliv. 2018, 25, 1103–1116.
   PubMed Web of Science ®Google Scholar
• Zhao, D.; Zhao, X.; Zu, Y.; Li, J.; Zhang, Y.; Jiang, R.; Zhang, Z. Preparation, Characterization, and In Vitro Targeted Delivery of Folate-Decorated Paclitaxel-Loaded Bovine Serum Albumin Nanoparticles. Int. J. Nanomed. 2010, 5, 669–677.
   PubMed Web of Science ®Google Scholar
• Subia, B.; Kundu, S.C. Drug Loading and Release on Tumor Cells Using Silk Fibroin–Albumin Nanoparticles as Carriers. Nanotechnology. 2013, 24, 035103.
   PubMed Web of Science ®Google Scholar
• Ferlay, J.; Shin, H.R.; Bray, F.; Forman, D.; Mathers, C.; Parkin, D.M. Estimates of Worldwide Burden of Cancer in 2008: GLOBOCAN 2008. Int. J. Cancer. 2010, 127, 2893–2917.
   PubMed Web of Science ®Google Scholar
• Shen, Z.; Zhan, G.; Ye, D.; Ren, Y.; Cheng, L.; Wu, Z.; Guo, J. MicroRNA-34a Affects the Occurrence of Laryngeal Squamous Cell Carcinoma by Targeting the Antiapoptotic Gene Survivin. Med. Oncol. 2012, 29, 2473–2480.
   PubMed Web of Science ®Google Scholar
• Marioni, G.; Marchese-Ragona, R.; Cartei, G.; Marchese, F.; Staffieri, A. Current Opinion in Diagnosis and Treatment of Laryngeal Carcinoma. Cancer Treat. Rev. 2006, 32, 504–515.
   PubMed Web of Science ®Google Scholar
• Murphy, B.A.; Gilbert, J.; Ridner, S.H. Systemic and Global Toxicities of Head and Neck Treatment. Expert Rev Anticancer Ther. 2007, 7, 1043–1053.
   PubMed Web of Science ®Google Scholar
• Wu, T.T.; Zhou, S.H. Nanoparticle-Based Targeted Therapeutics in Head-and-Neck Cancer. Int. J. Med. Sci. 2015, 12, 187–200.
   PubMed Web of Science ®Google Scholar
• Zhang, F.; Yang, B.; Shi, S.; Jiang, X. RNA Interference (RNAi) Mediated Stable Knockdown of Protein Casein Kinase 2-Alpha (CK2alpha) Inhibits Migration and Invasion and Enhances Cisplatin Induced Apoptosis in HEp-2 Laryngeal Carcinoma Cells. Acta Histochem. 2014, 116, 1000–1006.
   PubMed Web of Science ®Google Scholar
• Järvinen, A.K.; Autio, R.; Haapa-Paananen, S.; Wolf, M.; Saarela, M.; Grénman, R.; Leivo, I.; Kallioniemi, O.; Mäkitie, A. A.; Monni, O. Identification of Target Genes in Laryngeal Squamous Cell Carcinoma by High-Resolution Copy Number and Gene Expression Microarray Analyses. Oncogene. 2006, 25, 6997–7008.
   PubMed Web of Science ®Google Scholar
• Liu, Y.F.; Zhang, J.G.; Ni, H.S.; Liu, H.; Zhang, S.; Huang, H.; Shi, G.S. Expression and Significance of Angiopoietin-2 and Cyclin D1 in Laryngeal Squamous Cell Carcinoma and the Correlation with Prognosis. Exp. Ther. Med. 2013, 6, 1137–1144.
   PubMed Web of Science ®Google Scholar
• Dim, N.; Perepelyuk, M.; Gomes, O.; Thangavel, C.; Liu, Y.; Den, R.; Lakshmikuttyamma, A.; Shoyele, S.A. Novel Targeted siRNA-Loaded Hybrid Nanoparticles: Preparation, Characterization and In Vitro Evaluation. J. Nanobiotechnol. 2015, 13, 61.
   PubMed Web of Science ®Google Scholar
• Yu, K.S.; Lin, M.M.; Lee, H.J.; Tae, K.S.; Kang, B.S.; Lee, J.H.; Lee, N.S.; Jeong, Y.G.; Han, S.Y.; Kim, D.K. Receptor-Meditated Endocytosis by Hyaluronic Acid@Superparamagnetic Nanovetor for Targeting of CD44-Overexpressing Tumor Cells. Nanomaterials 2016, 6, 149.
   Web of Science ®Google Scholar
• Lee, J.H.; Lee, K.; Moon, S.H.; Lee, Y.; Park, T.G.; Cheon, J. All-In-One Target-Cell-Specific Magnetic Nanoparticles for Simultaneous Molecular Imaging and siRNA Delivery. Angew. Chem. Int. Ed. 2009, 121, 4174–4179.
   Google Scholar
• Singh, H.D.; Wang, G.; Uludağ, H.; Unsworth, L.D. Poly-L-lysine-Coated Albumin Nanoparticles: Stability, Mechanism for Increasing In Vitro Enzymatic Resilience, and siRNA Release Characteristics. Acta Biomater. 2010, 6, 4277–4284.
   PubMed Web of Science ®Google Scholar
• Abbasi, S.; Paul, A.; Prakash, S. Investigation of siRNA-Loaded Polyethylenimine-Coated Human Serum Albumin Nanoparticle Complexes for the Treatment of Breast Cancer. Cell Biochem. Biophys. 2011, 61, 277–287.
   PubMed Web of Science ®Google Scholar
• Son, S.; Song, S.; Lee, S.J.; Min, S.; Kim, S.A.; Yhee, J.Y.; Huh, M.S.; Kwon, I.C.; Jeong, S.Y.; Byun, Y.; et al. Self-Crosslinked Human Serum Albumin Nanocarriers for Systemic Delivery of Polymerized siRNA to Tumors. Biomaterials 2013, 34, 9475–9485.
   PubMed Web of Science ®Google Scholar
• Nicolì, E.; Syga, M.I.; Bosetti, M.; Shastri, V.P. Enhanced Gene Silencing through Human Serum Albumin-Mediated Delivery of Polyethylenimine-siRNA Polyplexes. PLoS One. 2015, 10, e0122581.
   PubMed Web of Science ®Google Scholar
• Langer, K.; Balthasar, S.; Vogel, V.; Dinauer, N.; Von Briesen, H.; Schubert, D. Optimization of the Preparation Process for Human Serum Albumin (HSA) Nanoparticles. Int. J. Pharm. 2003, 257, 169–180.
   PubMed Web of Science ®Google Scholar
• Malhotra, A.; Mittal, B.R. siRNA Gene Therapy Using Albumin as a Carrier. Pharmacogenet Genomics. 2014, 24, 582–587.
   PubMed Web of Science ®Google Scholar
• Mansoori, B.; Shotorbani, S.S.; Baradaran, B. RNA Interference and Its Role in Cancer Therapy. Adv. Pharm. Bull. 2014, 4, 313–321.
   PubMedGoogle Scholar
• Young, S.W.S.; Stenzel, M.; Jia-Lin, Y. Nanoparticle-siRNA: A Potential Cancer Therapy?. Crit. Rev. Oncol. Hematol. 2016, 98, 159–169.
   PubMed Web of Science ®Google Scholar
• Karnati, H.K.; Yalagala, R.S.; Undi, R.; Pasupuleti, S.R.; Gutti, R.K. Therapeutic Potential of siRNA and DNAzymes in Cancer. Tumour Biol. 2014, 35, 9505–9521.
   PubMedGoogle Scholar
• Cengiz, B.B.; Aşık, M.D.; Kara, G.; Turk, M.; Denkbas, E.B. Therapeutic Potential of Inhibiting ABCE1 and eRF3 Genes via siRNA Strategy Using Chitosan Nanoparticles in Breast Cancer Cells. J. Nanopart. Res. 2015, 17, 168.
   Web of Science ®Google Scholar
• Zhao, P.; Wang, H.; Yu, M.; Liao, Z.; Wang, X.; Zhang, F.; Ji, W.; Wu, B.; Han, J.; Zhang, H.; et al. Paclitaxel Loaded Folic Acid Targeted Nanoparticles of Mixed Lipid-Shell and Polymer-Core: In Vitro and In Vivo Evaluation. Eur. J. Pharm. Biopharm. 2012, 81, 248–256.
   PubMed Web of Science ®Google Scholar
• Ma, D. Enhancing Endosomal Escape for Nanoparticle Mediated siRNA Delivery. Nanoscale. 2014, 6, 6415–6425.
   PubMed Web of Science ®Google Scholar
• Kato, Y.; Ozawa, S.; Miyamoto, C.; Maehata, Y.; Suzuki, A.; Maeda, T.; Baba, Y. Acidic Extracellular Microenvironment and Cancer. Cancer Cell Int. 2013, 13, 89.
   PubMed Web of Science ®Google Scholar
• Han, J.; Wang, Q.; Zhang, Z.; Gong, T.; Sun, X. Cationic Bovine Serum Albumin Based Self-Assembled Nanoparticles as siRNA Delivery Vector for Treating Lung Metastatic Cancer. Small. 2014, 10, 524–535.
   PubMed Web of Science ®Google Scholar
• Zhang, F.; Yang, B.; Shi, S.; Jiang, X. RNA interference (RNAi) mediated stable knockdown of protein casein kinase 2-alpha (CK2α) inhibits migration and invasion and enhances cisplatin-induced apoptosis in HEp-2 laryngeal carcinoma cells. Acta Histochem. 2014, 116, 1000–1006.
   PubMed Web of Science ®Google Scholar